Company news

Jade Biosciences, Inc. news in 2024

Jade Biosciences, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement

October 30, 2024

Aerovate Therapeutics to Explore Strategic Alternatives

July 7, 2024

Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension

June 16, 2024

Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference

May 20, 2024

Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights

May 12, 2024

Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference

March 26, 2024

Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights

March 24, 2024

Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair

March 5, 2024

Decks in 2024